Plante Moran Financial Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.24K Buy
160
+10
+7% +$360 ﹤0.01% 636
2026
Q1
$5.3K Hold
150
﹤0.01% 561
2025
Q4
$6.09K Hold
150
﹤0.01% 621
2025
Q3
$7.05K Hold
150
﹤0.01% 580
2025
Q2
$7.81K Hold
150
﹤0.01% 595
2025
Q1
$9.06K Hold
150
﹤0.01% 583
2024
Q4
$10.3K Hold
150
﹤0.01% 572
2024
Q3
$10.8K Hold
150
﹤0.01% 599
2024
Q2
$10.4K Hold
150
﹤0.01% 579
2024
Q1
$12K Hold
150
﹤0.01% 580
2023
Q4
$16.4K Hold
150
﹤0.01% 480
2023
Q3
$15.1K Hold
150
﹤0.01% 472
2023
Q2
$20.4K Hold
150
﹤0.01% 440
2023
Q1
$15.6K Buy
+150
New +$14.5K ﹤0.01% 502

Other funds holding CNMD

Plante Moran Financial Advisors's CNMD Position: Q2 2026 in Review

Plante Moran Financial Advisors increased its CONMED (CNMD) stake by 6.7% in Q2 2026, buying an estimated $360 and bringing the position to 160 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

Plante Moran Financial Advisors first reported a position in CNMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $20.4K in Q2 2023. 93 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Plante Moran Financial Advisors held 160 shares of CONMED worth $5.24K as of Q2 2026.
  • Plante Moran Financial Advisors bought 10 CONMED shares in Q2 2026, an estimated $360.
  • CONMED made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #636 holding.
  • Plante Moran Financial Advisors first reported a position in CONMED in Q1 2023 and has held it in 14 quarters since.
  • Plante Moran Financial Advisors's CONMED position peaked at $20.4K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.